HPH-15, a compound developed by Kumamoto University, reduces blood glucose and fat accumulation more effectively than ...

Danish drug maker Novo Nordisk said on Thursday it will reduce the U.S. list prices of two insulin products by more than 70% ...

Novo will drop its U.S. list price for its Fiasp by 75% and for Tresiba by 72%, the Danish company said in a release. The new ...

Under "Your Drug List," list all of your drugs ... Because your brand of insulin is not covered in the 2025 Medicare Part D plan you are enrolled in, search through the prescription drug plans ...